Oxytocin Antagonist in Patients With Repeated Failure of Implantation

Implantation Failure Clinical Trial

Official title:
Oxytocin Antagonist in Patients With Repeated Failure of Implantation. A Prospective Randomized Placebo-controlled Double-blind Study.

Status Completed

Clinical Trial Summary

In this study the investigators compare the usual way of embryo transfer (without medication) with an embryo transfer while administering oxytocine antagonist. This to improve implantation and increase the pregnancy rate.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Implantation Failure

Clinical Trial Details

NCT number	NCT01673399
Study type	Interventional
Source	AZ Jan Palfijn Gent
Contact
Status	Completed
Phase	Phase 4
Start date	February 2012
Completion date	February 2015

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT01689454` - ISM1 Versus EmbrioGen Media for Embryo Culture With Previous Failure Implantation in ART Treatments	Phase 3
Completed	`NCT03843112` - Modulating the Vaginal Microbiome After Implantation Failure	Phase 4
Recruiting	`NCT01111799` - Does Local Injury of the Endometrium Improve Controlled Ovarian Hyperstimulation (COH) + Intrauterine Insemination (IUI) Outcome?	N/A
Completed	`NCT03153787` - Vaginal Microbiome Influence on the Results of Assisted Reproduction Techniques	N/A
Recruiting	`NCT06097559` - International Non-selection Study for ERA® Test in Patients With Previous Implantation Failures
Recruiting	`NCT01800513` - Endometrial Biopsy Prior to IVF in Those Patients With Prior Implantation Failure	N/A
Active, not recruiting	`NCT03558399` - Frozen Blastocyst Transfer Using Conventional Timing Versus Timing by Endometrial Receptivity Analysis	N/A